Online training STRIDE II guidelines in inflammatory bowel disease – A case-based discussion. Gastroenterology and Hepatology Partner Content RX Training with partner View Post
View Post This content is machine translated A case-based discussion Optimization of perioperative care in IBD. The perioperative care of IBD patients is crucial for optimizing the treatment outcome. Close contact with the surgeon and the joint assessment, care and treatment of patients enable customized medical and nutritional therapy with the best results. In this way, the increased morbidity and six-fold increase in mortality associated with emergency surgery for IBD patients can be avoided…. This content can only be access by registered users. Log In Register CME-Test View Post
View Post This content is machine translated ONLINE TRAINING Optimization of perioperative care in IBD. In this case-based discussion, Prof. Michel Adamina, MD, Chief of the Clinic for Visceral and Thoracic Surgery at the Winterthur Cantonal Hospital, PD Pascal Juillerat, MD, a specialist in gastroenterology and hepatology at the Centre Crohn et colite in Lausanne, and Maude Martinho-Grüber, MD, a specialist in gastroenterology at the Clinique de la Source in Lausanne, provide an overview of optimizing perioperative care in IBD…. This content can only be access by registered users. Log In Register CME-Test View Post
View Post This content is machine translated Inflammatory Bowel Disease (IBD) STRIDE II Guideline Recommendations The STRIDE II supplement includes evidence- and consensus-based recommendations for targeted treatment strategies in adults and children with IBD. Confirmed that the most important long-term achievable treatment goals for patients are clinical remission, endoscopic cure, restoration of quality of life, and absence of disability…. This content can only be access by registered users. Log In Register CME-Test View Post
View Post This content is machine translated 8th IBDnet Postgraduate Course Inflammatory bowel disease – Are my treatment goals worth it? The therapeutic landscape for inflammatory bowel disease (IBD) has expanded greatly in recent years. As a result, increasingly ambitious therapeutic goals are becoming realistic [1]. But is it worth steadily tightening them up and what are the potential risks involved? Prof. Raja Atreya explored these questions at the IBDnet Postgraduate Course…. This content can only be access by registered users. Log In Register View Post
View Post This content is machine translated Stratification of IBD patients “I hope that soon we will be able to identify the optimal treatment for each patient.” Dutch gastroenterologist Professor Janneke Van der Woude, Erasmus University Medical Center in Rotterdam, explains the increasing importance of patient stratification in IBD management in an interview on the occasion of the eighth Swiss IBD Roadshow supported by AbbVie…. This content can only be access by registered users. Log In Register View Post
View Post This content is machine translated Chronic inflammatory bowel disease The new STRIDE II recommendations in practice: “You have to aim high!” Interview with Prof. Dr. med. Axel Dignass The new STRIDE II recommendations define time-dependent therapeutic targets in inflammatory bowel disease (IBD)[1]. How can these be implemented in practice and why is mucosal healing a realistic goal for more and more patients?… This content can only be access by registered users. Log In Register View Post
View Post This content is machine translated Expert Podcast Quality assurance in IBD – Where are we today? The management of inflammatory bowel disease (IBD) is complex and requires high quality standards of care and treatment. In the following expert podcast, Sophie Buyse, MD, and Prof. Stephan Vavricka, MD, discuss what is important in quality assurance on the occasion of the partial revision of Article 58 of the KVG. Listen in!… This content can only be access by registered users. Log In Register View Post
